Psychological disorders: diagnosis, controversy, and the limits of classification

Intuition Beginner

Imagine a woman in nineteenth-century London who hears voices that no one else hears. Her family takes her to Bethlem Royal Hospital — known colloquially as Bedlam — where she is locked in a cell, chained to a wall, and occasionally displayed to paying visitors as a public spectacle. Her "treatment" consists of cold baths, purgatives, and bloodletting. She will likely spend the rest of her life there.

Now imagine a woman in twenty-first-century Chicago who hears voices that no one else hears. A psychiatrist diagnoses her with schizophrenia. She is prescribed an antipsychotic medication, meets with a therapist weekly, and joins a support group. Her symptoms diminish. She lives in her own apartment, holds a job, and maintains relationships. The voices do not entirely go away, but she learns to manage them.

Both women have similar experiences. The difference is not in what they go through but in how their society understands and responds to it. That difference — between chains and medication, between spectacle and support — is the history of mental illness treatment in a single contrast.

This unit is about psychological disorders: what they are, how they are classified, how they have been treated, and why classification itself is controversial. The central tension is this: the DSM (Diagnostic and Statistical Manual of Mental Disorders) is the most widely used classification system for mental disorders in the world, and it is also one of the most criticised documents in all of medicine. It is a useful tool that helps millions of people access treatment. It has also classified normal human variation as illness, been influenced by pharmaceutical industry interests, and been shaped by cultural assumptions that do not generalise beyond the populations that produced them.

The unit covers the major categories of psychological disorder — anxiety, mood disorders, schizophrenia, eating disorders, substance use, trauma — but it also covers the critical perspectives that every student of psychology should understand. The fact that homosexuality was classified as a mental disorder until 1973 is not a footnote. It is a cautionary tale about what happens when social prejudice is encoded in scientific nomenclature. The fact that most diagnostic criteria were developed studying White Western populations is not an oversight. It is a structural limitation that shapes who gets diagnosed, who gets treated, and whose suffering is recognised as legitimate.

A brief history of mental illness treatment Beginner

The history of how societies have treated people we now call "mentally ill" is not a story of steady progress. It is a story of cycles — cycles of humane reform followed by neglect, of scientific optimism followed by abuse, of institutionalisation followed by abandonment.

In many premodern societies, unusual mental states were understood through spiritual or religious frameworks. Ancient Greek physicians like Hippocrates attributed mental disturbance to imbalances in bodily humours — an early biological theory. In medieval Europe, mental illness was often interpreted through a religious lens: as possession by demons, as divine punishment, or as a spiritual trial. Exorcism, prayer, and pilgrimage were common treatments. This was not uniformly cruel — some religious communities provided care for people with mental disturbances — but it could be, especially when unusual behaviour was interpreted as witchcraft.

The asylum era began in earnest in the eighteenth and nineteenth centuries. Initially, asylums were founded with reformist intentions. Philippe Pinel in France and William Tuke in England advocated for "moral treatment" — the idea that people with mental illness deserved kindness, respect, and a structured environment rather than chains and punishment. Pinel famously unchained patients at Bicetre Hospital in Paris in 1795, an act that became a symbol of humanitarian reform ^{[source pending]}.

But asylums rapidly became warehouses. In the United States, the state hospital system expanded through the nineteenth century. Dorothea Dix campaigned successfully for the construction of public asylums, arguing that people with mental illness deserved care rather than incarceration in jails and poorhouses. By the late nineteenth century, these institutions were severely overcrowded. "Moral treatment" gave way to custodial care. Patients lived in large wards with minimal individual attention. Restraints, isolation cells, and forced labour were common. Many people entered asylums and never left.

The twentieth century brought new treatments, some of which now look barbaric. Insulin coma therapy (injecting patients with insulin to induce seizures and comas) was used in the 1930s and 1940s. Electroconvulsive therapy (ECT), introduced in 1938, was administered without anaesthesia or muscle relaxants, causing violent seizures and sometimes broken bones. ECT in its modern form — with anaesthesia, muscle relaxants, and precise electrical dosing — is a different procedure and remains an effective treatment for severe depression that has not responded to medication. But its history colours public perception.

The prefrontal lobotomy, developed by Portuguese neurologist Egas Moniz in 1935 and popularised in the United States by Walter Freeman, involved severing connections in the prefrontal cortex. Moniz received the Nobel Prize in Medicine in 1949 for this procedure. Approximately 40,000 to 50,000 lobotomies were performed in the United States between the late 1930s and the 1960s. The procedure left many patients permanently disabled — emotionally flat, cognitively impaired, and unable to function independently. That a lobotomy was considered legitimate medical treatment, and that its inventor received the highest honour in medicine, is a reminder that "standard of care" does not guarantee "correct" ^{[source pending]}.

Deinstitutionalisation began in the 1960s and accelerated through the 1970s and 1980s. Several factors drove it. The discovery of antipsychotic medications (chlorpromazine, marketed as Thorazine, in 1954) made it possible for many people with severe mental illness to live outside institutions, at least while taking medication. A series of investigative reports and legal cases exposed the horrific conditions in many state hospitals. The 1975 Supreme Court decision O'Connor v. Donaldson established that a state cannot constitutionally confine a non-dangerous individual who is capable of surviving safely in freedom. Fiscal conservatives saw deinstitutionalisation as a way to save money. Civil libertarians saw it as a matter of rights.

The result was the mass release of hundreds of thousands of people from state hospitals. Between 1955 and 1994, the number of people in US state psychiatric hospitals fell from approximately 560,000 to about 70,000. But the community mental health centres that were supposed to replace institutional care were never adequately funded. Many people released from hospitals ended up homeless, in prison, or in crisis. The United States now has more people with serious mental illness in jails and prisons than in hospitals. Deinstitutionalisation was a necessary correction, but the failure to fund community-based alternatives turned a reform into a different kind of crisis ^{[source pending]}.

The DSM system Beginner

The Diagnostic and Statistical Manual of Mental Disorders (DSM) is published by the American Psychiatric Association. It is the standard reference used by psychiatrists, psychologists, counsellors, insurance companies, and researchers in the United States and many other countries to classify and diagnose mental disorders.

The DSM has gone through multiple editions. DSM-I (1952) contained 106 diagnoses. DSM-II (1968) expanded to 182. DSM-III (1980), the most consequential revision, introduced explicit diagnostic criteria for each disorder and a multiaxial system, largely in response to the reliability crisis — the finding that different psychiatrists examining the same patient often reached different diagnoses. DSM-III-R (1987), DSM-IV (1994), DSM-IV-TR (2000), DSM-5 (2013), and DSM-5-TR (2022) followed, each with revisions and additions. DSM-5-TR contains over 300 diagnoses.

The DSM defines each disorder by a list of criteria. To receive a diagnosis, a person must meet a specified number of criteria from a list, and the symptoms must cause clinically significant distress or impairment in functioning. A diagnosis of major depressive disorder, for example, requires at least five of nine symptoms (including depressed mood or loss of interest) present for at least two weeks, and the symptoms must cause significant impairment.

The DSM is useful for several reasons. It provides a common language that allows clinicians and researchers to communicate about specific conditions. It enables insurance reimbursement — a diagnosis is typically required for insurance to cover treatment. It facilitates research by defining groups of people with similar symptoms who can be studied and compared. And it can provide relief and validation to people whose suffering has been dismissed or misunderstood.

But the DSM is also a lightning rod for criticism, and the criticisms are substantive.

The problem of medicalisation. Each new edition of the DSM has added new disorders. Grief after bereavement can now be diagnosed as major depressive disorder (DSM-5 removed the "bereavement exclusion" that previously prevented this). Childhood temper tantrums can be diagnosed as disruptive mood dysregulation disorder. Ordinary forgetfulness in ageing can be diagnosed as mild neurocognitive disorder. Allen Frances, the chair of the DSM-IV task force, became one of the DSM-5's most vocal critics, arguing that the expansion of diagnostic criteria was turning normal human variation into mental illness ^{[source pending]}.

The influence of pharmaceutical companies. The DSM does not recommend treatments, but each new diagnosis creates a market for medication. Pharmaceutical companies have had extensive financial ties to DSM panel members. A 2006 analysis found that 56% of DSM-IV panel members had financial ties to the pharmaceutical industry. The relationship is not conspiratorial in the simple sense — nobody sits in a room deciding to invent disorders to sell pills — but it is structural. When the definition of a disorder is broadened, more people qualify for diagnosis, and more prescriptions follow.

The question of validity. Reliability (do different clinicians reach the same diagnosis?) and validity (does the diagnosis correspond to a real, distinct entity in the world?) are different. The DSM has improved reliability since DSM-III. Validity remains contested. Thomas Insel, then director of the National Institute of Mental Health, wrote in 2013 that "the weakness of the DSM is its lack of validity" and that "patients with mental disorders deserve better." He announced that NIMH would be reorienting research away from DSM categories toward the Research Domain Criteria (RDoC) project, which aims to understand mental disorders in terms of biological systems rather than symptom checklists ^{[source pending]}.

Comorbidity. DSM diagnoses overlap enormously. A person diagnosed with major depression often also meets criteria for an anxiety disorder. A person with borderline personality disorder often also meets criteria for PTSD, depression, and an eating disorder. If these were truly distinct diseases, you would not expect them to co-occur so frequently. The high rate of comorbidity suggests that the DSM's categorical boundaries may not map cleanly onto the underlying structure of mental illness.

The role of culture. The DSM's diagnostic criteria were developed primarily by White, Western, English-speaking psychiatrists studying primarily White, Western, English-speaking patients. The DSM-5 includes a "Cultural Formulation Interview" and a glossary of cultural concepts of distress, but these are appendages to a system whose core categories assume a particular cultural framework. Whether depression looks the same in rural China as it does in suburban Chicago is an empirical question, and the evidence suggests it does not ^{[source pending]}.

Homosexuality as a mental disorder: a cautionary tale Beginner

From 1952 (DSM-I) until 1973, homosexuality was classified as a mental disorder. It appeared as a "sociopathic personality disturbance" in DSM-I and as a "sexual deviation" in DSM-II.

This was not a fringe position. It was the mainstream psychiatric consensus, supported by psychoanalytic theory (which held that homosexuality resulted from disturbed parent-child relationships), by the assumption that anything non-normative was pathological, and by the simple fact that the people writing the DSM were products of a culture that condemned homosexuality.

The classification had real consequences. It legitimised conversion therapy — the attempt to change a person's sexual orientation through psychological or behavioural interventions. It was cited in legal proceedings to justify discrimination. It gave the appearance of scientific authority to moral judgement.

The removal of homosexuality from the DSM in 1973 was not the result of new research proving that homosexuality was normal. It was the result of activism. Gay rights activists, including Frank Kameny and Barbara Gittings, protested at APA conferences. Evelyn Hooker's research in the 1950s had demonstrated that expert clinicians could not distinguish between homosexual and heterosexual men on the basis of psychological test results — undermining the claim that homosexuality was inherently pathological. But it was political pressure, combined with a growing body of evidence, that forced the change ^{[source pending]}.

Even the 1973 decision was a compromise. Homosexuality was replaced with "ego-dystonic homosexuality" — distress about one's homosexual orientation — which remained in the DSM until 1987. The message was: being gay is not a disorder, but wishing you were not gay is. This compromise preserved a diagnostic category for clinicians who wanted to continue treating homosexuality as a problem.

The history is important not as an embarrassment to be acknowledged and dismissed, but as a structural warning. If the psychiatric establishment could be this wrong about homosexuality — wrong in a way that damaged millions of lives — what else might it be wrong about? Not everything in the DSM is wrong. But the authority of the DSM is not a guarantee of truth. It is a snapshot of consensus at a particular moment, and consensus is shaped by culture, politics, and power, not only by evidence.

The parallels to current debates are direct. The classification of gender dysphoria in the DSM-5-TR is contested. Some argue that a diagnosis is necessary for access to gender-affirming medical care. Others argue that pathologising gender variance reproduces the same error that was made with homosexuality — treating a natural variation in human experience as a disorder because it departs from social norms.

Anxiety disorders Beginner

Anxiety is a normal human emotion. It becomes a disorder when it is disproportionate to the actual threat, persistent beyond the triggering situation, and severe enough to interfere with daily functioning. Anxiety disorders are the most common category of mental disorder, affecting approximately 30% of adults at some point in their lives.

Generalised anxiety disorder (GAD) involves excessive, difficult-to-control worry about multiple areas of life (health, finances, work, relationships) lasting at least six months, accompanied by physical symptoms such as restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbance. The worry in GAD is not about a specific threat but about life in general. It is the experience of being on constant alert, waiting for something to go wrong, even when nothing specific is wrong.

Panic disorder involves recurrent, unexpected panic attacks — sudden surges of intense fear accompanied by physical symptoms such as heart palpitations, sweating, trembling, shortness of breath, chest pain, and a feeling of impending doom. Many people who experience their first panic attack go to the emergency room believing they are having a heart attack. The fear of future panic attacks (anticipatory anxiety) and the avoidance of situations where attacks might occur can become more disabling than the attacks themselves.

Phobias are intense, irrational fears of specific objects or situations. Specific phobias (spiders, heights, needles, enclosed spaces) are the most common. Social anxiety disorder — intense fear of social situations where one might be judged, embarrassed, or humiliated — is particularly disabling because social interaction is central to human life.

Obsessive-compulsive disorder (OCD), reclassified from the anxiety disorders category to its own category in DSM-5, involves intrusive, unwanted thoughts (obsessions) and repetitive behaviours or mental acts performed to reduce the anxiety those thoughts produce (compulsions). A person with contamination obsessions may wash their hands dozens of times a day until the skin bleeds. A person with doubt obsessions may check the stove repeatedly, unable to trust their own memory that they turned it off. The person usually recognises that the obsessions are irrational, but the anxiety is overwhelming regardless.

The critical point for understanding anxiety disorders is that the anxiety system itself is functional — it evolved to detect and respond to threats. Anxiety disorders represent the system misfiring: responding to non-threats as if they were dangerous, or failing to turn off once a real threat has passed. This is not a broken system; it is a system operating in overdrive.

Mood disorders Beginner

Major depressive disorder (MDD) is not sadness. Sadness is a normal, appropriate response to loss, disappointment, or grief. Major depression is a persistent state (at least two weeks, often much longer) of depressed mood or loss of interest in nearly all activities, accompanied by symptoms such as significant weight change, insomnia or hypersomnia, psychomotor agitation or retardation, fatigue, feelings of worthlessness or excessive guilt, difficulty thinking or concentrating, and recurrent thoughts of death or suicide. A person with major depression may feel that nothing will ever improve, that they are fundamentally flawed, and that the world would be better off without them. These are not passing thoughts. They are sustained, pervasive, and often resistant to evidence ^{[source pending]}.

Major depression is not rare. The World Health Organisation lists it as a leading cause of disability worldwide. It is not a Western invention. Cross-cultural research finds depression in every society studied, though its presentation varies — in many East Asian and African contexts, depression more often manifests through physical complaints (headaches, fatigue, gastrointestinal distress) than through verbalised emotional pain.

Bipolar disorder (formerly manic-depressive illness) involves episodes of major depression alternating with episodes of mania or hypomania. A manic episode is a distinct period of abnormally elevated, expansive, or irritable mood lasting at least one week, accompanied by symptoms such as grandiosity, decreased need for sleep, pressured speech, racing thoughts, distractibility, increased goal-directed activity, and excessive involvement in risky behaviours (spending sprees, sexual indiscretions, reckless driving). Hypomania is a less severe version that does not cause marked impairment.

Bipolar I disorder requires at least one manic episode. Bipolar II disorder requires at least one hypomanic episode and at least one major depressive episode. The distinction matters because the treatment is different — antidepressant medication without a mood stabiliser can trigger manic episodes in bipolar patients.

The depressive phase of bipolar disorder is often what brings people to treatment, because mania can feel good (or at least energising), while depression feels unbearable. This means bipolar disorder is frequently misdiagnosed as unipolar depression, sometimes for years, with consequences for treatment.

Schizophrenia Beginner

Schizophrenia is one of the most severe and misunderstood mental disorders. The name, coined by Eugen Bleuler in 1908, means "split mind" — not split personality, which is a different condition (dissociative identity disorder). The "split" refers to a fragmentation of thought processes, emotion, and behaviour.

Positive symptoms are additions to normal experience: hallucinations (perceiving things that are not there, most commonly hearing voices), delusions (fixed false beliefs not shared by the person's cultural community, such as believing one is being persecuted by a government agency or that one's thoughts are being broadcast on television), disorganised speech (loose associations, jumping between unrelated topics), and disorganised or catatonic behaviour.

Negative symptoms are subtractions from normal experience: flat affect (reduced emotional expression), alogia (reduced speech), avolition (reduced motivation), anhedonia (reduced ability to experience pleasure), and asociality (reduced social engagement). Negative symptoms are often more disabling than positive symptoms because they are harder to treat and because they erode the person's ability to function in daily life.

Cognitive symptoms include difficulties with working memory, attention, and executive function. These are present from the onset of the disorder and are not well-treated by current medications.

Schizophrenia affects approximately 1% of the population worldwide, across cultures. The course varies enormously. Some people have a single psychotic episode and recover fully. Others experience chronic, debilitating symptoms that do not respond to treatment. Most fall somewhere between these extremes.

People with schizophrenia are far more likely to be victims of violence than perpetrators. The popular association of schizophrenia with dangerousness is a media myth that has caused enormous harm by fuelling stigma and fear.

The life expectancy of people with schizophrenia is reduced by approximately 15-20 years, largely due to cardiovascular disease, diabetes, and suicide. Antipsychotic medications have serious metabolic side effects (weight gain, diabetes risk, movement disorders), and the decision to take them involves weighing benefits against significant costs.

Eating disorders Beginner

Anorexia nervosa involves restriction of food intake leading to significantly low body weight, an intense fear of gaining weight or becoming fat, and a disturbance in how one's body weight or shape is experienced. People with anorexia may see themselves as overweight even when they are dangerously thin. Anorexia has the highest mortality rate of any mental disorder — between 5% and 20% of people with anorexia die from its medical complications or from suicide.

Bulimia nervosa involves episodes of binge eating (eating an unusually large amount of food in a discrete period, with a sense of loss of control) followed by compensatory behaviours such as vomiting, laxative use, fasting, or excessive exercise. Unlike anorexia, people with bulimia are typically at or near normal weight, which can make the disorder less visible.

Binge-eating disorder, added to the DSM in 2013, involves recurrent binge-eating episodes without compensatory behaviours. It is more common than anorexia and bulimia combined.

Eating disorders are often framed as disorders of vanity or as products of Western thinness ideals. This is reductive. Eating disorders involve complex interactions of genetic vulnerability, neurobiology (serotonin and dopamine systems), personality traits (perfectionism, harm avoidance), family dynamics, and cultural context. While Western media ideals of thinness contribute to body dissatisfaction, they are neither necessary nor sufficient to produce an eating disorder.

Eating disorders exist in non-Western cultures, though their presentation and prevalence vary. In Hong Kong, for instance, Sing Lee documented a form of anorexia in which patients restricted food without expressing fear of fatness — they reported feeling bloated or simply stopped eating, often in response to stress. This variant did not match DSM criteria, and patients who presented this way were sometimes denied diagnosis and treatment ^{[source pending]}.

Substance use disorders Beginner

Substance use disorders involve the continued use of alcohol or drugs despite significant negative consequences. The DSM-5 uses a single category (substance use disorder, ranging from mild to severe) rather than the older distinction between "abuse" and "dependence."

Diagnostic criteria include impaired control (using more than intended, unsuccessful efforts to cut down), social impairment (failure to fulfil major role obligations, continued use despite social problems), risky use (using in physically dangerous situations), and pharmacological indicators (tolerance — needing more to achieve the same effect — and withdrawal — negative symptoms when use stops).

Addiction is not simply a failure of willpower. Substances act on the brain's reward system, particularly the mesolimbic dopamine pathway, in ways that produce powerful reinforcement. Repeated use produces neuroadaptations that make the brain dependent on the substance to function normally. The choice model ("just stop using") fails to account for the neurobiological changes that make stopping extraordinarily difficult.

But the disease model is also incomplete. Cultural context, social determinants (poverty, trauma, lack of opportunity), and the meaning that substance use has in a person's life all matter. Rat studies in the 1970s showed that rats isolated in bare cages would self-administer morphine until they died. Bruce Alexander's "Rat Park" experiments showed that rats housed in enriched environments with social interaction and stimulation largely ignored morphine-laced water. The implication: addiction is not just about the substance. It is about the environment in which the person (or rat) lives.

The current opioid crisis in the United States illustrates the interaction of neurobiology, industry, and social conditions. Purdue Pharma aggressively marketed OxyContin as having a low addiction risk, a claim that was false. Prescription rates skyrocketed. When prescriptions became harder to obtain, many people turned to heroin and then to fentanyl. The crisis has killed over 500,000 Americans since 1999 and has been concentrated in communities experiencing economic decline, social isolation, and loss of meaning — the human equivalent of the bare cage.

Trauma and PTSD Beginner

Post-traumatic stress disorder (PTSD) can develop after exposure to a traumatic event — actual or threatened death, serious injury, or sexual violence. Symptoms fall into four clusters: intrusion (involuntary memories, nightmares, flashbacks), avoidance (of trauma-related thoughts, feelings, or external reminders), negative alterations in cognition and mood (inability to remember aspects of the trauma, negative beliefs about oneself or the world, persistent negative emotions, detachment from others), and alterations in arousal and reactivity (hypervigilance, exaggerated startle response, irritability, sleep disturbance).

PTSD was formally recognised in DSM-III (1980), largely as a result of advocacy by Vietnam veterans and their clinicians who observed that many veterans experienced severe, persistent psychological symptoms long after returning from combat. The recognition of PTSD was itself a political act: it acknowledged that the environment — not just the individual — could cause mental illness.

Not everyone who experiences trauma develops PTSD. Approximately 70% of adults experience at least one traumatic event in their lifetime, but only about 7-8% develop PTSD. Risk factors include the severity and duration of the trauma, prior trauma history (childhood adversity is a potent risk factor), lack of social support, and genetic vulnerability. Resilience is the norm, not the exception — most people recover from trauma without developing a disorder. But resilience is not a character trait; it is influenced by social support, economic resources, and the availability of coping strategies.

Complex PTSD, proposed for ICD-11 but not included in the DSM, describes the effects of prolonged, repeated trauma — particularly childhood abuse or domestic violence — that produces symptoms beyond classic PTSD, including difficulties with emotional regulation, identity, and relationships.

The concept of trauma has expanded considerably in recent decades, and this expansion is itself contested. Some clinicians argue that broadening the definition of trauma to include indirect exposure (learning about a traumatic event happening to someone else) or non-life-threatening events pathologises normal distress. Others argue that restricting the definition to narrowly defined "Criterion A" events excludes many people whose suffering is real.

Neurodiversity: autism and ADHD Beginner

The concept of neurodiversity — a term coined by sociologist Judy Singer in the late 1990s — proposes that neurological differences such as autism and ADHD are natural variations in human cognition rather than disorders to be cured. This section presents both the medical model and the neurodiversity paradigm, because both capture something real.

Autism spectrum disorder (ASD) is characterised by persistent deficits in social communication and social interaction across multiple contexts, and restricted, repetitive patterns of behaviour, interests, or activities. These symptoms are present from early development and cause clinically significant impairment in functioning. The DSM-5 merged what were previously separate diagnoses (autistic disorder, Asperger's syndrome, pervasive developmental disorder not otherwise specified) into a single spectrum.

The medical model of autism emphasises that autistic people face real difficulties. Many autistic people have intellectual disability (though many do not). Many have difficulty with spoken language. Many experience sensory hypersensitivity that makes everyday environments (shopping malls, classrooms, open-plan offices) painful. Many have high rates of co-occurring anxiety, depression, and epilepsy. Seizure risk in autism is substantially elevated. Life expectancy is reduced. These are not social constructs; they are real challenges that can be devastating.

The neurodiversity paradigm does not deny these challenges. Instead, it reframes the question of where the disability comes from. Damian Milton's double empathy problem argues that the communication difficulties between autistic and non-autistic people are bidirectional: non-autistic people are equally poor at understanding autistic communication, but this is framed as an autistic deficit because non-autistic people are the numerical majority and hold social power ^{[source pending]}.

The neurodiversity paradigm argues that many of the difficulties autistic people face are caused by a society designed for neurotypical cognition: environments that are sensorily overwhelming, social norms that require performative eye contact and small talk, educational systems that privilege one mode of learning, and employment practices that filter out people who do not interview "normally."

Both perspectives are true. An autistic person who cannot tolerate the sensory environment of a workplace experiences real suffering. That suffering is partly a product of their neurological difference (the sensory sensitivity itself) and partly a product of the environment (the workplace could be redesigned with quiet spaces, dim lighting, and fewer social demands). The medical model asks: how do we change the person? The neurodiversity paradigm asks: how do we change the environment? The best approach does both.

Attention-deficit/hyperactivity disorder (ADHD) involves a persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. The DSM-5 requires that several symptoms be present before age twelve, and that they be present in two or more settings (home, school, work).

ADHD is one of the most medicated conditions in psychiatry. Stimulant medications (methylphenidate, amphetamine) are effective for many people, improving attention and reducing hyperactivity. They are also potentially abusable and can have side effects including appetite suppression, sleep disruption, and, in rare cases, cardiovascular problems.

The neurodiversity perspective on ADHD argues that inattention and hyperactivity are not deficits in all contexts. In environments that require rapid shifting between tasks, high energy, and willingness to take risks, ADHD traits can be advantages. The evolutionary hypothesis — that ADHD traits were adaptive in hunter-gatherer environments where constant environmental scanning and quick response were valuable — is speculative but illustrates the point: what counts as a disorder depends on what the environment demands.

The history of both autism and ADHD diagnosis reveals disparities. White boys are diagnosed with autism and ADHD at higher rates than girls, children of colour, and children from low-income families — not because these conditions are more common in White boys, but because the diagnostic criteria were developed by studying White boys, and because access to evaluation is unequal. Girls with autism are more likely to be missed because they may "mask" (consciously or unconsciously imitating neurotypical social behaviour) more effectively than boys. The under-diagnosis of autism in girls, women, people of colour, and people in low-income countries is a failure of the diagnostic system, not a feature of the disorders.

Cultural-bound syndromes Beginner

If mental illness were a purely biological phenomenon, you would expect it to look the same everywhere. It does not. The form that psychological suffering takes is shaped by the cultural context in which a person lives. Cultural-bound syndromes (also called cultural concepts of distress) are patterns of abnormal behaviour or experience that are specific to a particular culture or group.

This does not mean that these conditions are "fake" or that they exist "only" in certain cultures. All mental illness is culturally shaped. Western mental disorders are cultural-bound syndromes too — they are just so familiar to the people who created the DSM that they appear universal rather than culturally specific. The term "cultural-bound syndrome" can misleadingly imply that Western diagnostic categories are culture-free. They are not.

Koro is a condition found primarily in Southeast Asia (particularly Malaysia, Indonesia, and southern China) characterised by an intense fear that the genitals are retracting into the body and that this will cause death. Epidemics of koro have been documented, in which hundreds of people in a community simultaneously develop the fear. A biological explanation (a disorder of body image) would miss the social dimension: koro epidemics typically occur during periods of social stress or uncertainty, and the fear spreads through social contagion.

Amok (the origin of the English phrase "running amok") is a syndrome found primarily in Malaysia, Indonesia, and the Philippines. It involves a sudden, unprovoked episode of rage during which a person (traditionally a man) attacks people and objects indiscriminately, often ending in the person's death (by suicide or by being killed by others). The person typically has no memory of the episode afterward. It is associated with a cultural context in which emotional expression — particularly anger — is strongly suppressed, and in which a person who has suffered severe loss of face or social standing may see no other way out.

Susto (fright sickness) is found in Latin American cultures. It is attributed to a traumatic event that causes the soul to leave the body, producing symptoms such as appetite loss, sleep disturbance, sadness, lethargy, and feelings of worthlessness. The Western diagnosis might be depression or an adjustment disorder, but for the person experiencing susto, the problem is not a chemical imbalance but a spiritual one, and the treatment involves rituals to call the soul back.

Hikikomori is a Japanese phenomenon in which a person (typically a young man) withdraws entirely from social life, staying in their bedroom in their parents' home for months or years, refusing to attend school or work, and interacting with family members only minimally. Estimates suggest that hundreds of thousands of people in Japan are in this state. Hikikomori is not in the DSM. It is deeply embedded in Japanese cultural context: the intense pressure to conform to social expectations, the stigma of failure, the availability of internet-based entertainment that allows withdrawal without complete isolation, and the cultural tolerance for a parent supporting an adult child at home.

Ataque de nervios, common among Caribbean Latinx populations, involves screaming, crying, trembling, verbal or physical aggression, and a sense of being out of control, often triggered by a stressful family event. It resembles a panic attack but has distinct cultural meaning and is understood within a framework of emotional distress that is recognised and validated by the community.

Taijin kyofusho, also Japanese, involves an intense fear that one's body, body parts, or body functions are offensive, embarrassing, or displeasing to others. It resembles social anxiety disorder but is oriented outward (fear of harming or discomforting others) rather than inward (fear of being judged). The distinction reflects a cultural emphasis on social harmony and the impact of one's behaviour on others.

These conditions illustrate a fundamental point: mental illness is not experienced identically across cultures. The raw material of suffering — pain, fear, grief, confusion, despair — may be universal, but the form it takes, the meaning it has, and the way a community responds to it are culturally shaped. This is not an argument against biological approaches to mental illness. It is an argument for understanding that biology and culture interact at every level ^{[source pending]}.

Cultural approaches to healing Beginner

Western psychotherapy and psychopharmacology are not the only ways to treat mental illness, and they are not universally regarded as the best. Different cultures have developed different approaches to psychological healing, and these approaches are not merely "traditional" or "pre-scientific" — many of them incorporate genuine understanding of the relationship between individual suffering and social context.

Shamanic healing, practiced in various forms across Indigenous cultures worldwide, involves a practitioner entering an altered state of consciousness to interact with the spirit world on behalf of a person who is suffering. The Western psychiatric framing would dismiss this as superstition. A more nuanced view recognises that shamanic healing addresses the social and spiritual dimensions of suffering that Western psychiatry often ignores: the person's relationship to their community, to their ancestors, to the natural world, and to meaning. The ritual itself — which is typically communal, involving family and community members — provides social support, narrative framework, and a shared understanding of the person's distress. These are therapeutic elements that Western therapy also provides, through different means.

Community healing models in many African cultures treat mental illness as a community problem rather than an individual one. The Zulu concept of ubuntu ("I am because we are") implies that a person's well-being is inseparable from the well-being of their community. Treatment involves restoring the person's relationships and social role, not merely alleviating individual symptoms. Family meetings, communal rituals, and the involvement of extended kin networks are standard. Western individual therapy, in which a person sits alone with a therapist and discusses their private thoughts, can feel isolating and unnatural in cultures where the self is understood as relational rather than individual.

Family-based treatment is the norm in many Asian and Latin American cultures. In Japan, a person with mental illness is typically treated within the family context, with family members actively involved in treatment decisions. In many Latin American cultures, curanderismo — traditional folk healing — involves the entire family in healing rituals. Western psychiatry's emphasis on individual autonomy and patient privacy is not wrong, but it reflects a particular cultural value (individualism) that is not universal.

The integration question. The question is not whether Western psychiatry or traditional healing is better. The question is how to integrate the genuine insights of both. Western psychiatry has effective treatments (medications, evidence-based psychotherapies) that traditional healers do not have. Traditional healing systems have understanding of community, meaning, ritual, and cultural context that Western psychiatry often lacks. People in many cultures already use both systems simultaneously — consulting a psychiatrist and a traditional healer, taking medication and participating in healing rituals — and report benefit from both. The insistence that one system must be correct and the other wrong is itself a culturally specific attitude.

Visual Beginner

The timeline shows that treatment approaches and classification systems have co-evolved. Each era produced both genuine advances and serious errors. The lobotomy was a scientific treatment; its inventor won a Nobel Prize. Homosexuality was a scientific diagnosis; it was supported by the leading psychiatrists of the day. The lesson is not that science is untrustworthy but that scientific consensus in psychiatry is more provisional than in fields where empirical validation is more straightforward.

Worked example: Diagnostic reasoning Beginner

A 34-year-old woman presents to her primary care doctor reporting that she has felt "terrible" for the past three weeks. She describes waking up at 3 AM every night and being unable to get back to sleep. She has lost seven pounds without trying. She cries frequently, sometimes without a clear trigger. She has stopped going to her book club and avoids calls from friends. She says she feels "worthless" and "like a burden." She mentions that her mother died two months ago.

The doctor considers two DSM-5 diagnoses:

Major depressive disorder. The patient reports depressed mood, insomnia, weight loss, loss of interest in activities, feelings of worthlessness, and social withdrawal. She meets at least six of the nine criteria for MDD. The symptoms have lasted more than two weeks and cause significant impairment.

Normal grief (bereavement). The patient's mother died two months ago. Grief shares many features with depression: sadness, sleep disturbance, appetite changes, social withdrawal, and waves of intense emotional pain. DSM-5 removed the bereavement exclusion that previously prevented diagnosing MDD within two months of bereavement. This means that a doctor can now diagnose depression in a grieving person.

How does the clinician distinguish between grief and major depression in this case? Key features that suggest depression rather than grief include: feelings of worthlessness (grief typically involves sadness about the loss, not self-condemnation), pervasive loss of interest in all activities (grief often allows for moments of pleasure or engagement), and the severity and persistence of insomnia. In grief, positive emotions and humour typically surface in waves between periods of sadness. In depression, the darkness is more constant.

But the boundary is genuinely blurry, and the DSM-5's removal of the bereavement exclusion is itself contested. Critics argue that it medicalises a normal human process. Proponents argue that bereavement-related depression responds to the same treatments as other depression and that denying diagnosis denies access to treatment.

This case illustrates the fundamental challenge of psychiatric diagnosis: the categories are useful but the boundaries are drawn through judgment, not through a laboratory test.

Check your understanding Beginner

Formal definitions and diagnostic frameworks Intermediate

Wakefield's harmful dysfunction analysis

Jerome Wakefield proposed that a condition should be classified as a mental disorder only if it meets two criteria: (1) it involves a dysfunction of some psychological mechanism — the mechanism is not performing a function it was biologically designed to perform, and (2) the dysfunction causes harm — it is judged to be undesirable based on social values and norms ^{[source pending]}.

Formally: a condition $C$ is a mental disorder if and only if:

1. $C$ involves a failure of some internal mechanism $M$ to perform a function $f$ for which $M$ was selected (evolutionary or biological design sense).
2. $C$ causes harm to the individual, as judged by the standards of the individual's culture (normative sense).

This analysis attempts to ground the concept of disorder in both factual (dysfunction) and normative (harm) components. A condition that involves dysfunction but no harm (for example, a rare cognitive style that does not impair functioning) would not be a disorder. A condition that involves harm but no dysfunction (for example, the distress of being oppressed) would not be a disorder either.

Critics have noted several problems. The concept of "natural function" is difficult to pin down without circularity. Evolutionary design is itself a contested framework — many traits are evolutionary by-products rather than adaptations, and the distinction matters for determining whether a mechanism is "designed" to do something. The reliance on cultural values for the harm criterion means that what counts as a disorder can change across cultures and across time — which is exactly what the analysis is trying to avoid.

Key experiment: Rosenhan's "On Being Sane in Insane Places" Intermediate

In 1973, David Rosenhan published one of the most influential experiments in the history of psychiatry. Eight pseudopatients (including Rosenhan himself) presented at twelve different psychiatric hospitals complaining of hearing voices that said "empty," "hollow," and "thud." Apart from this single fabricated symptom and the false names and occupations they gave, they answered all questions truthfully and behaved normally.

All eight were admitted. Seven were diagnosed with schizophrenia and one with manic-depressive psychosis. Their stays ranged from 7 to 52 days, with an average of 19 days. Once admitted, the pseudopatients behaved normally and no longer reported hearing voices. Despite this, their normal behaviour was often interpreted through the lens of their diagnosis. Pacing the halls out of boredom was recorded as "nervousness." Taking notes was described in nursing records as "writing behaviour." One pseudopatient overheard a psychiatrist teaching students that the pseudopatient's history showed "ambivalence in the mother-child relationship."

When Rosenhan's results were published, a prominent hospital challenged him to send pseudopatients and promised to detect them. Rosenhan agreed. Over the next three months, the hospital confidently identified 41 out of 193 new patients as suspected pseudopatients. Rosenhan had sent no one.

The study demonstrated that the psychiatric label, once applied, shaped how all subsequent behaviour was interpreted. It raised questions about the reliability of psychiatric diagnosis and about the institutional dynamics of mental hospitals. It also had methodological limitations: the sample was small, the hospitals were not randomly selected, and the study has not been replicated. But its impact on the field was enormous, contributing to the push for more rigorous diagnostic criteria in DSM-III ^{[source pending]}.

Key model: The biopsychosocial model Intermediate

The biopsychosocial model, proposed by George Engel in 1977, holds that mental disorders arise from the interaction of biological, psychological, and social factors. No single level of explanation is sufficient.

• Biological factors: genetics, neurochemistry, brain structure, hormonal systems, immune function, and pharmacological effects.
• Psychological factors: cognitive patterns, emotional regulation, learned associations, trauma history, personality traits, and coping strategies.
• Social factors: poverty, discrimination, social support, family dynamics, cultural norms, community resources, and institutional structures.

The model is not a specific theory but a framework that insists on multiple levels of analysis. Depression, for example, is not "caused by" a serotonin deficit, a history of childhood abuse, or social isolation. It arises from the interaction of genetic vulnerability (heritability of approximately 37%), neurochemical factors (involving serotonin, norepinephrine, dopamine, and the HPA axis), cognitive patterns (negative automatic thoughts, learned helplessness), and social context (loss, isolation, chronic stress, poverty).

The biopsychosocial model is widely endorsed in principle but difficult to implement in practice. A fifteen-minute medication management appointment does not allow for exploration of social factors. Insurance reimbursement structures incentivise brief, medication-focused treatment over comprehensive assessment. The model is a useful corrective to purely biological or purely psychological approaches, but it can also become a vague gesture toward complexity without specifying how the levels actually interact.

Evidence pattern: The diathesis-stress model Intermediate

The diathesis-stress model provides a framework for understanding how disorders develop. A diathesis is a vulnerability or predisposition — genetic, biological, or psychological. Stress refers to adverse experiences or environmental demands. The model proposes that disorders emerge when a vulnerable individual encounters sufficient stress.

The model explains why not everyone exposed to the same stressor develops the same disorder. Two people experience the same traumatic event. One develops PTSD, the other does not. The difference lies in the diathesis: prior trauma history, genetic vulnerability (the FKBP5 gene has been implicated in stress-response modulation), social support, and coping resources all influence whether stress is sufficient to trigger disorder in a given individual.

The diathesis-stress model applies across disorders. For schizophrenia, the diathesis may be genetic (having a first-degree relative with schizophrenia increases risk approximately tenfold) and the stress may be cannabis use, urban upbringing, or social adversity. For depression, the diathesis may be a cognitive style that attributes negative events to internal, stable, and global causes, and the stress may be a major life event. For substance use disorders, the diathesis may include genetic vulnerability (heritability estimated at 40-60%) and the stress may include peer influence, availability of the substance, and life stress.

Formal definition: Diagnostic validity Intermediate

Robins and Guze (1970) proposed five criteria for establishing the validity of a psychiatric diagnosis:

1. Clinical description: the disorder has a characteristic set of symptoms and course.
2. Laboratory studies: there are objective measures that distinguish the disorder from other conditions.
3. Delimitation from other disorders: the disorder can be distinguished from similar conditions (exclusion criteria).
4. Follow-up study: patients with the diagnosis show a characteristic outcome over time.
5. Family study: the disorder aggregates in families at higher rates than in the general population.

Kendell and Jablensky (2003) distinguished between validity (the diagnostic category corresponds to a real, distinct entity with natural boundaries) and utility (the category is useful for clinical communication, treatment selection, and prognosis). They argued that few psychiatric diagnoses meet strict validity criteria but many have demonstrated utility. The DSM categories are useful tools that do not necessarily carve nature at its joints.

This distinction matters because it reframes the debate. The question "Is major depressive disorder a real disease?" is less productive than "Is the construct of major depressive disorder useful for predicting treatment response, course, and outcome?" The answer to the second question is yes, with important caveats about heterogeneity within the category and overlap with other categories.

Exercises Intermediate

Core model: The DSM-5-TR diagnostic criteria structure Intermediate

The DSM-5-TR organises each diagnosis with the following structure:

• Diagnostic criteria: A list of required symptoms, with a specified threshold (e.g., "five or more of the following nine symptoms").
• Duration criterion: Symptoms must be present for a specified minimum duration (e.g., at least two weeks for major depressive disorder, at least six months for GAD).
• Clinical significance criterion: Symptoms must cause "clinically significant distress or impairment in social, occupational, or other important areas of functioning."
• Exclusion criteria: The symptoms must not be better explained by another condition, substance use, or a medical condition.

The clinical significance criterion is particularly important — and particularly contested. It is the boundary between normal experience and disorder. Without it, anyone who has ever felt anxious, sad, or distracted could qualify for a diagnosis. With it, the determination of what counts as "clinically significant" is a matter of clinical judgment, which introduces subjectivity.

Key result: Inter-rater reliability of DSM diagnoses Intermediate

The DSM-III revision was motivated largely by poor inter-rater reliability — the finding that different clinicians examining the same patient often reached different diagnoses. DSM-III introduced explicit criteria to address this.

The DSM-5 field trials (conducted 2010-2012) tested inter-rater reliability for selected diagnoses using intraclass correlation coefficients (ICC) or kappa statistics. Results were mixed:

• Good reliability (kappa > 0.60): major neurocognitive disorder, PTSD
• Questionable reliability (kappa 0.20-0.40): major depressive disorder, generalised anxiety disorder
• Poor reliability (kappa < 0.20): mixed anxiety-depressive disorder

These results mean that for some of the most common diagnoses — depression and anxiety — two clinicians evaluating the same patient have a meaningful chance of reaching different diagnostic conclusions. This is a limitation of the categorical approach, not evidence that the conditions are unreal.

The ICD system Intermediate

The International Classification of Diseases (ICD), published by the World Health Organisation, is the other major classification system for mental disorders. ICD-11 (2022) is used in most countries outside the United States and is the system used for WHO global health statistics.

Key differences from the DSM:

• ICD is produced by an international body (WHO) rather than a national professional association (APA). Its development involved clinicians and researchers from over 50 countries.
• ICD-11 includes a chapter on "Culture-Related Diagnostic Issues" for each disorder, integrated into the main text rather than appended.
• ICD-11 includes complex PTSD as a distinct diagnosis (not in DSM-5-TR).
• ICD codes are used for billing and epidemiological tracking worldwide, making the ICD arguably more globally significant than the DSM despite the latter's dominance in American psychiatry.

Connections to other disciplines Master

Psychological disorders do not exist in isolation from the rest of knowledge. The classification and treatment of mental illness connects to neuroscience (the biological basis of disorders), philosophy (the question of what constitutes a "disorder"), sociology (the social determinants of mental health), anthropology (the cultural shaping of symptoms), history (how societies have understood and treated mental illness), economics (the cost of mental illness and the influence of the pharmaceutical industry), and ethics (the rights of people diagnosed with mental disorders, the use of psychiatric diagnosis for social control).

The epidemiology of mental disorders connects to public health. Walker and Druss (2023) documented the cumulative mortality burden of mental disorders: people with serious mental illness die 15-25 years earlier than the general population, primarily from treatable medical conditions. This "mortality gap" has widened in recent decades, suggesting that the healthcare system systematically fails people with mental illness.

The genetics of mental disorders connects to biology. Genome-wide association studies (GWAS) have identified hundreds of genetic variants associated with psychiatric conditions, but each variant explains a tiny fraction of risk. The genetic architecture of most mental disorders is highly polygenic — many variants, each of small effect, combine with environmental factors to produce vulnerability. Schizophrenia, for example, has an estimated heritability of approximately 80%, but identical twins are concordant for schizophrenia only about 40-50% of the time, meaning that genes are not destiny.

The philosophy of psychiatry connects to philosophy of science and ethics. The question "What is a mental disorder?" is not purely empirical; it requires a conceptual analysis of what it means for a condition to be a disorder. Wakefield's harmful dysfunction analysis is one attempt; others include Boorse's biostatistical theory, which defines health as statistical normality of function, and Cooper's pragmatic approach, which defines disorder in terms of what it is useful for a medical profession to treat.

The anthropology of mental illness connects to the study of culture. Arthur Kleinman's work in China demonstrated that depression presented primarily as somatic complaints (headache, dizziness, fatigue) rather than as emotional distress, and that Chinese physicians often did not recognise these presentations as depression. This is not because Chinese people experience depression differently at a biological level (they may or may not), but because the cultural framework for understanding suffering gives priority to physical rather than emotional symptoms. When the diagnostic criteria assume an emotional presentation, people whose suffering is somatically expressed are missed.

Historical and philosophical context Master

The anti-psychiatry movement

The 1960s and 1970s saw the emergence of the anti-psychiatry movement, which questioned whether mental illness was a real medical condition at all. Thomas Szasz, in The Myth of Mental Illness (1961), argued that mental illness is a metaphor — the mind cannot be "ill" in the way the body can, because illness is a physical phenomenon. Szasz saw psychiatric diagnosis as a mechanism of social control, a way of pathologising deviance and enforcing conformity.

R.D. Laing, in The Divided Self (1960) and The Politics of Experience (1967), argued that schizophrenia was not a disease but a rational response to an insane world — specifically, to the contradictory, impossible demands placed on a person by a dysfunctional family system. Laing's ideas were influential in the counterculture but have not stood up well empirically. Schizophrenia has a strong genetic component and occurs in families that are not dysfunctional. Blaming families for causing schizophrenia caused enormous guilt and distress among parents who had done nothing wrong.

Michel Foucault, in Madness and Civilisation (1961), traced the history of how Western societies have defined, confined, and treated "madness," arguing that the concept of mental illness and the institutions that manage it are mechanisms of social control rather than medical care.

The anti-psychiatry movement overreached. Mental illness is not a myth — the suffering of a person with severe depression, schizophrenia, or anorexia is real, debilitating, and sometimes fatal. Antipsychotic medications, for all their side effects, are genuinely effective for many people. But the anti-psychiatry critique captured something important: psychiatric diagnosis is not a neutral, purely scientific act. It is embedded in social and political context, and it can be used to pathologise deviance, enforce conformity, and control behaviour. The challenge is to take this critique seriously without concluding that mental illness does not exist.

The replication crisis in psychiatry

Psychiatry shares the replication crisis that has shaken psychology and other sciences. Many widely cited findings — specific gene associations, neurotransmitter hypotheses, brain imaging results — have failed to replicate. The serotonin hypothesis of depression (the idea that depression is caused by low serotonin levels) has been substantially revised. A 2022 umbrella review by Moncrieff et al. found no consistent evidence of an association between serotonin and depression, challenging the simplified neurotransmitter story that has been used to market SSRI antidepressants. This does not mean SSRIs do not work (they do, for many people, though their effect sizes are modest) — it means that the mechanism is more complex than the marketing suggests.

The pharmaceutical industry and psychiatric knowledge

The relationship between pharmaceutical companies and psychiatric practice is not merely a matter of individual corruption. It is structural. Pharmaceutical companies fund a large proportion of clinical trials for psychiatric medications. They fund continuing medical education for psychiatrists. They fund patient advocacy organisations that promote awareness of specific disorders. They employ key opinion leaders who present at conferences and write treatment guidelines. They have had financial ties to DSM panel members.

This does not mean that psychiatric medications are a scam. Many are genuinely effective. But it does mean that the knowledge base of psychiatry is not produced in a neutral environment. The conditions that get the most research attention are the conditions for which medication is most marketable. The boundaries of diagnostic categories are influenced by the potential market size. The presentation of research findings is shaped by commercial interests — published trials are more likely to report positive results, and negative trials may be suppressed.

Allen Frances, the DSM-IV chair, described the problem plainly: "Drug companies have a vested interest in expanding diagnostic boundaries to increase the market for their products. This is not a conspiracy theory. It is a straightforward account of how a profit-driven industry naturally behaves."

Decolonising psychiatric diagnosis

Gone and Kirmayer (2020) have argued that the DSM's categories reflect a Western epistemology that is not universally applicable. Indigenous concepts of mental health in many cultures do not separate "mental" from "physical" from "spiritual" in the way Western psychiatry does. The DSM's emphasis on individual symptoms, diagnosed through individual interview, reflects the Western emphasis on the individual as the unit of analysis. Many Indigenous healing traditions understand distress as a disturbance in relationships — between the person and their family, community, land, ancestors, and spiritual world — that cannot be reduced to a list of individual symptoms.

The inclusion of the Cultural Formulation Interview in DSM-5 was a step toward acknowledging cultural context, but critics argue it is a superficial addition to a system whose fundamental assumptions remain Western. The question of whether the DSM can be "decolonised" through incremental revision — or whether it requires a fundamentally different approach to understanding mental health — remains open.

The philosopher's stone: Hacking on transient mental illnesses

Ian Hacking, in Mad Travelers (1998), introduced the concept of transient mental illnesses — conditions that appear in a specific cultural and historical context, flourish for a period, and then largely disappear. His case study was fugue (or "mad travelling"), a condition in which a person suddenly leaves home, travels to a distant place, assumes a new identity, and has no memory of their former life. Fugue appeared in France in the late nineteenth century, was diagnosed in hundreds of cases, and then largely disappeared.

Hacking argued that fugue was real — the people who experienced it were genuinely suffering — but that it was also a product of its time. The condition was "made up" in the sense that the cultural concept of fugue provided a template for how certain kinds of distress could be expressed. Once the cultural template changed (with new diagnostic categories, new social conditions, new ways of understanding the self), the condition faded.

This analysis applies to contemporary conditions. Whether the increase in autism diagnoses reflects a real increase in the condition, better detection, or a broadening of the diagnostic concept (or all three) is debated. Whether the rise in ADHD diagnoses in the United States reflects better awareness, pharmaceutical marketing, or a cultural shift in how inattention is understood is contested. Hacking's framework suggests that these questions are not answerable by biology alone — they require understanding how cultural concepts interact with human experience.

The future of classification Master

Several developments are shaping the future of psychiatric classification:

The NIMH Research Domain Criteria (RDoC) project aims to understand mental disorders in terms of basic neurobiological systems (negative valence, positive valence, cognitive systems, social processes, arousal/regulation) rather than symptom-based categories. Insel's 2013 announcement that NIMH would reorient funding away from DSM-based research toward RDoC was widely interpreted as a rejection of the DSM. In practice, RDoC has been difficult to implement clinically. Patients do not present with "negative valence system dysfunction" — they present with anxiety, depression, or psychosis. RDoC may inform the next generation of classification systems, but it does not replace the need for clinically useful categories.

Computational approaches use machine learning and large datasets to identify patterns in symptoms, genetics, neuroimaging, and outcomes that may cut across DSM categories. The network theory of psychopathology (Borsboom) proposes that mental disorders are not latent entities that cause symptoms but networks of mutually reinforcing symptoms — the insomnia causes the fatigue, which causes the difficulty concentrating, which causes the poor performance, which causes the low mood, which causes the insomnia. Treatment targets the strongest connections in the network rather than an underlying "disorder."

Dimensional approaches propose replacing categorical diagnoses with continuous measures of symptom severity. The DSM-5 introduced dimensional severity ratings for some disorders, but retained categorical thresholds. A fully dimensional system would classify people along multiple continua (mood, anxiety, psychosis, cognition, personality) rather than assigning them to discrete categories. This would better capture the continuous nature of psychopathology — there is no bright line between normal sadness and clinical depression — but would be more difficult to use in clinical practice and insurance billing.

Cross-cultural integration requires that any future classification system be developed with genuine input from diverse cultural perspectives, not merely appended to a Western framework. The ICD-11, developed with input from clinicians in over 50 countries, represents a step in this direction. But the deeper challenge is epistemological: whether a single, universal classification system is possible or desirable, given that different cultures understand and experience mental suffering in fundamentally different ways.

Bibliography Master

Primary sources

• American Psychiatric Association. (1952). Diagnostic and Statistical Manual: Mental Disorders (1st ed.).

• American Psychiatric Association. (1968). Diagnostic and Statistical Manual of Mental Disorders (2nd ed.).

• American Psychiatric Association. (1980). Diagnostic and Statistical Manual of Mental Disorders (3rd ed.).

• American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.).

• American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text revision).

• Engel, G. L. (1977). "The need for a new medical model: A challenge for biomedicine." Science, 196(4286), 129-136.

• Foucault, M. (1961). Folie et deraison: Histoire de la folie a l'age classique (Madness and Civilisation). Plon.

• Frances, A. (2013). Saving Normal: An Insider's Revolt Against Out-of-Control Psychiatric Diagnosis, DSM-5, Big Pharma, and the Medicalization of Ordinary Life. William Morrow.

• Hacking, I. (1998). Mad Travelers: Reflections on the Reality of Transient Mental Illnesses. Harvard University Press.

• Hooker, E. (1957). "The adjustment of the male overt homosexual." Journal of Projective Techniques, 21(1), 18-31.

• Kirk, S. A. and Kutchins, H. (1992). The Selling of DSM: The Rhetoric of Science in Psychiatry. Aldine de Gruyter.

• Kleinman, A. (1988). Rethinking Psychiatry: From Cultural Category to Personal Experience. Free Press.

• Laing, R. D. (1960). The Divided Self: An Existential Study in Sanity and Madness. Tavistock.

• Milton, D. E. (2012). "On the ontological status of autism: The 'double empathy problem'." Disability and Society, 27(6), 883-887.

• Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., and Horowitz, M. A. (2022). "The serotonin theory of depression: A systematic umbrella review of the evidence." Molecular Psychiatry, 28, 3243-3256.

• Reed, G. M., First, M. B., et al. (2019). "The ICD-11 developmental field study of reliability of diagnoses of high-burden mental disorders." World Psychiatry, 18(1), 71-79.

• Robins, E. and Guze, S. B. (1970). "Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia." American Journal of Psychiatry, 126(7), 983-987.

• Rosenhan, D. L. (1973). "On being sane in insane places." Science, 179(4070), 250-258.

• Shorter, E. (1997). A History of Psychiatry: From the Era of the Asylum to the Age of Prozac. Wiley.

• Szasz, T. (1961). The Myth of Mental Illness: Foundations of a Theory of Personal Conduct. Hoeber-Harper.

• Wakefield, J. C. (1992). "The concept of mental disorder: On the boundary between biological facts and social values." American Psychologist, 47(3), 373-388.

Secondary sources

• Comer, R. J. (2021). Abnormal Psychology (11th ed.). Worth Publishers.
• Cosgrove, L. and Whitaker, E. (2020). Psychiatry Under the Influence: Institutional and Corporate Corruption, Social Injury, and Prospects for Reform. Palgrave Macmillan.
• Gone, J. P. and Kirmayer, L. J. (2020). "Decolonizing and indigenizing the DSM-5." In DSM-5-TR, pp. 877-894.
• Horwitz, A. V. (2002). Creating Mental Illness. University of Chicago Press.
• Insel, T. R. (2013). "Director's Blog: Transforming Diagnosis." National Institute of Mental Health.
• Kawa, S. and Giordano, J. (2012). "A brief historicity of the Diagnostic and Statistical Manual of Mental Disorders." Philosophy, Ethics, and Humanities in Medicine, 7, 2.
• Kendell, R. and Jablensky, A. (2003). "Distinguishing validity and utility in psychiatric diagnoses." American Journal of Psychiatry, 160(1), 4-12.
• Kirmayer, L. J. (2001). "Cultural variations in the clinical presentation of depression and anxiety." Journal of Clinical Psychiatry, 62(suppl 13), 22-28.
• Nolen-Hoeksema, S. (2020). Abnormal Psychology (8th ed.). McGraw-Hill.
• Walker, E. R. and Druss, B. G. (2023). "Cumulative burden of comorbid mental disorders, substance use disorders, chronic medical conditions, and poverty on mortality among adults in the US." JAMA Psychiatry, 80(6), 630-637.